IMPROVING THE OCULAR ABSORPTION OF PHENYLEPHRINE

被引：17

作者：

CHIEN, DS ^{[1
]}

SCHOENWALD, RD ^{[1
]}

机构：

[1] UNIV IOWA,COLL PHARM,DIV PHARMACEUT,IOWA CITY,IA 52242

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1986年 / 7卷 / 05期

关键词：

D O I：

10.1002/bdd.2510070506

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：453 / 462

页数：10

共 11 条

[1]

BERGAMINI MVW, 1979, INVEST OPHTHALMOL S, V187

[2] PRO-DRUGS AS DRUG DELIVERY SYSTEMS .20. OXAZOLIDINES AS POTENTIAL PRO-DRUG TYPES FOR BETA-AMINOALCOHOLS, ALDEHYDES OR KETONES [J].

BUNDGAARD, H ;

JOHANSEN, M .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 10 (02) :165-175

[3]

BURR LA, 1984, INT J PHARM, V18, P325

[4]

FRANFELDER FT, 1978, ARCH OPHTHALMOL, V41, P447

[5] CORNEAL PENETRATION BEHAVIOR OF BETA-BLOCKING-AGENTS .2. ASSESSMENT OF BARRIER CONTRIBUTIONS [J].

HUANG, HS ;

SCHOENWALD, RD ;

LACH, JL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (11) :1272-1279

[6] SYSTEMIC ABSORPTION AND CARDIOVASCULAR EFFECTS OF PHENYLEPHRINE EYEDROPS [J].

KUMAR, V ;

SCHOENWALD, RD ;

CHIEN, DS ;

PACKER, AJ ;

CHOI, WW .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1985, 99 (02) :180-184

[7]

MINDEL JS, 1980, ARCH OPHTHALMOL-CHIC, V98, P2220

[8]

SCHOENWALD RD, 1985, CONTROLLED DRUG BIOA, V3, P258

[9]

TRIGGLE DJ, 1970, MED CHEM, P1248

[10]

WASLEY RE, 1983, J OCULAR THER SURG, V2, P212

← 1 2 →